ARTICLE | Company News
Guilford obtains anesthetic compound
March 2, 2000 8:00 AM UTC
GLFD acquired worldwide exclusive development and commercialization rights to PQ-1002 (GPI-15715), an anesthetic agent developed by ProQuest (Lawrence, Kansas). The compound is a prodrug of propofol, ...